Spectrum Asset Management (California)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $522K | Buy |
18,597
+199
| +1% | +$5.3K | 0.17% | 72 |
|
|
2025
Q4 | $458K | Buy |
18,398
+586
| +3% | +$14.8K | 0.15% | 74 |
|
|
2025
Q3 | $454K | Buy |
17,812
+133
| +0.8% | +$3.28K | 0.16% | 76 |
|
|
2025
Q2 | $429K | Buy |
17,679
+619
| +4% | +$14.4K | 0.19% | 72 |
|
|
2025
Q1 | $432K | Buy |
17,060
+261
| +2% | +$6.83K | 0.19% | 61 |
|
|
2024
Q4 | $446K | Buy |
16,799
+459
| +3% | +$12.4K | 0.2% | 71 |
|
|
2024
Q3 | $473K | Buy |
16,340
+1,512
| +10% | +$44.1K | 0.2% | 67 |
|
|
2024
Q2 | $415K | Buy |
14,828
+228
| +2% | +$6.28K | 0.19% | 67 |
|
|
2024
Q1 | $405K | Buy |
+14,600
| New | +$405K | 0.17% | 70 |
|
|
2023
Q4 | – | Sell |
-7,040
| Closed | -$234K | – | 99 |
|
|
2023
Q3 | $234K | Hold |
7,040
| – | – | 0.12% | 80 |
|
|
2023
Q2 | $258K | Hold |
7,040
| – | – | 0.13% | 74 |
|
|
2023
Q1 | $287K | Hold |
7,040
| – | – | 0.14% | 73 |
|
|
2022
Q4 | $361K | Sell |
7,040
-125
| -2% | -$5.99K | 0.17% | 68 |
|
|
2022
Q3 | $313K | Buy |
7,165
+177
| +3% | +$8.6K | 0.16% | 68 |
|
|
2022
Q2 | $366K | Sell |
6,988
-155
| -2% | -$7.9K | 0.18% | 68 |
|
|
2022
Q1 | $370K | Hold |
7,143
| – | – | 0.15% | 82 |
|
|
2021
Q4 | $422K | Sell |
7,143
-32
| -0.4% | -$1.58K | 0.12% | 93 |
|
|
2021
Q3 | $309K | Hold |
7,175
| – | – | 0.1% | 98 |
|
|
2021
Q2 | $281K | Hold |
7,175
| – | – | 0.08% | 104 |
|
|
2021
Q1 | $260K | Buy |
7,175
+155
| +2% | +$5.5K | 0.08% | 109 |
|
|
2020
Q4 | $258K | Sell |
7,020
-674
| -9% | -$24.7K | 0.09% | 94 |
|
|
2020
Q3 | $268K | Sell |
7,694
-53
| -0.7% | -$1.86K | 0.11% | 87 |
|
|
2020
Q2 | $240K | Hold |
7,747
| – | – | 0.12% | 80 |
|
|
2020
Q1 | $240K | Sell |
7,747
-43,700
| -85% | -$1.49M | 0.23% | 70 |
|
|
2019
Q4 | $1.91M | Sell |
51,447
-1,501
| -3% | -$53.5K | 1.05% | 31 |
|
|
2019
Q3 | $1.8M | Hold |
52,948
| – | – | 1.16% | 26 |
|
|
2019
Q2 | $2.18M | Sell |
52,948
-42
| -0.1% | -$1.67K | 1.37% | 20 |
|
|
2019
Q1 | $2.13M | Buy |
52,990
+211
| +0.4% | +$8.45K | 1.44% | 17 |
|
|
2018
Q4 | $2.19M | Sell |
52,779
-212
| -0.4% | -$8.8K | 1.73% | 13 |
|
|
2018
Q3 | $2.22M | Buy |
52,991
+33,797
| +176% | +$1.3M | 1.32% | 15 |
|
|
2018
Q2 | $661K | Sell |
19,194
-1,413
| -7% | -$48.3K | 0.59% | 37 |
|
|
2018
Q1 | $716K | Buy |
20,607
+1,370
| +7% | +$47.1K | 0.63% | 38 |
|
|
2017
Q4 | $661K | Sell |
19,237
-264
| -1% | -$9K | 0.51% | 42 |
|
|
2017
Q3 | $661K | Buy |
19,501
+401
| +2% | +$12.9K | 0.57% | 36 |
|
|
2017
Q2 | $609K | Hold |
19,100
| – | – | 0.56% | 38 |
|
|
2017
Q1 | $620K | Buy |
19,100
+1,476
| +8% | +$46.5K | 0.57% | 41 |
|
|
2016
Q4 | $543K | Buy |
17,624
+3,267
| +23% | +$99.7K | 0.53% | 43 |
|
|
2016
Q3 | $461K | Hold |
14,357
| – | – | 0.5% | 34 |
|
|
2016
Q2 | $480K | Buy |
14,357
+6
| +0% | +$191 | 0.57% | 31 |
|
|
2016
Q1 | $404K | Hold |
14,351
| – | – | 0.51% | 32 |
|
|
2015
Q4 | $440K | Hold |
14,351
| – | – | 0.5% | 42 |
|
|
2015
Q3 | $428K | Hold |
14,351
| – | – | 0.5% | 38 |
|
|
2015
Q2 | $457K | Sell |
14,351
-316
| -2% | -$10.3K | 0.39% | 48 |
|
|
2015
Q1 | $484K | Hold |
14,667
| – | – | 0.43% | 41 |
|
|
2014
Q4 | $433K | Buy |
+14,667
| New | +$421K | 0.36% | 47 |
|
Other funds holding PFE
VCM
VPM
Spectrum Asset Management (California)'s PFE Position: Q1 2026 in Review
Spectrum Asset Management (California) increased its Pfizer (PFE) stake by 1.1% in Q1 2026, buying an estimated $5.3K and bringing the position to 18,597 shares worth $522K. The position accounts for 0.17% of the portfolio, ranked #72.
Spectrum Asset Management (California) first reported a position in PFE in Q4 2014 and has held it in 45 quarters since. The position peaked at $2.22M in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Spectrum Asset Management (California) held 18,597 shares of Pfizer worth $522K as of Q1 2026.
- Spectrum Asset Management (California) bought 199 Pfizer shares in Q1 2026, an estimated $5.3K.
- Pfizer made up 0.17% of Spectrum Asset Management (California)'s portfolio in Q1 2026, its #72 holding.
- Spectrum Asset Management (California) first reported a position in Pfizer in Q4 2014 and has held it in 45 quarters since.
- Spectrum Asset Management (California)'s Pfizer position peaked at $2.22M in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Spectrum Asset Management (California)'s 13F filing for Q1 2026, filed 22 Apr 2026.